Innateâ€™s sole drug in development, MIS416, is in clinical trials in Australia and New Zealand to evaluate whether it works in people with an advanced form of multiple sclerosis. A midlevel trial is underway, and results are due in the middle of this year. Experts in congressional ethics and trading rules said there did not appear to be evidence that Mr. Collins or Mr. Price used nonpublic information to steer their investment activities, a practice that would violate what is known as the Stock Act, which bans insider trading by members of Congress. But, said Donna M. Nagy, a law professor at Indiana University who has written on the financial investments by members of Congress, "One needs facts in order to get answers to those questions, and coming up with the facts for that is going to be difficult. 